Publish in this journal
Journal Information
Vol. 71. Issue 1.
Pages 51-53 (January 2018)
Share
Share
Download PDF
More article options
Vol. 71. Issue 1.
Pages 51-53 (January 2018)
Scientific letter
DOI: 10.1016/j.rec.2016.12.035
Full text access
A Rare Life-threatening Kodamaea ohmeri Endocarditis Associated With Hemophagocytic Lymphohistiocytosis
Inusual endocarditis grave por Kodamaea ohmeri asociada a linfohistiocitosis hemofagocítica
Visits
...
Buqing Nia, Weidong Gua, Yaning Meib, Kourong Miaoc, Shijiang Zhanga, Yongfeng Shaoa,
Corresponding author
523799912@qq.com

Corresponding author:
a Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
b Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
c Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
This item has received
...
Visits
(Daily data update)
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (1)
Table. Summary of the Characteristics of the Patients With K. ohmeri Endocarditis
Full Text
To the Editor,

We report the case of a 57-year-old man with a 3-month history of intermittent pyrexia. He received irregular antibacterial therapy and thrombolysis in a local hospital due to occlusion of the right distal popliteal artery. His medical history included multiple fractures, allergic purpura, and hypertension. His medications included prednisone (30mg orally per day), metoprolol, and amlodipine.

On physical examination, breath sounds were clear and a 3/6 pansystolic murmur was auscultated at the right sternal border. Swelling of the right leg and gangrene at the fifth toe were found. Abdominal palpation revealed mild splenomegaly. The following abnormal laboratory results were identified: white cell count, 3.20 × 109/L; platelet count, 30 × 109/L; hemoglobin, 8.80g/dL; albumin, 2.99g/dL; erythrocyte sedimentation rate, 42mm/h; C-reactive protein, 13.30mg/L; and ferritin, 674μg/L.

Three blood cultures were positive and a gram stain showed budding yeast cells. The isolate, after being subcultured on CHROMagar (Becton Dickinson, Paris, France), showed membranous colonies that changed color from pink to blue within 48hours (Figure A). On corn meal agar (Becton Dickinson), pseudohyphae and blastoconidia were seen 24hours later (Figure B). The yeasts were identified as Kodamaea ohmeri (K. ohmeri). Drug sensitivity testing showed that this strain was susceptible to voriconazole, fluconazole, itraconazole, and amphotericin B.

Figure.

A: Color change of K. ohmeri cultured on CHROMagar Candida medium. B: Subcultured on corn meal agar, the yeast shows pseudohyphae and blastoconidia. C: Bone marrow smear shows macrophage phagocytosis of a band neutrophil (red arrow), multiple red blood cells (green arrow), and platelets (blue arrow) (Giemsa stain; magnification, ×1000). D: Intraoperative view shows a large fragile and loose vegetation on the aortic valve that almost occludes the orifice.

(0.17MB).

Bone marrow aspiration, performed due to the cytopenia, showed phagocytosis of hematopoietic cells by activated macrophages (Figure C). Thoracoabdominal computed tomography revealed splenomegaly and mild bilateral pleural effusion. Transthoracic echocardiography showed a large vegetation (30mm × 12mm) on the aortic valve with mild regurgitation and stenosis.

On hospital day 5, the patient developed persistent pyrexia with a temperature of 39°C despite antifungal therapy with intravenous voriconazole. Urgent surgery was performed and a large fragile and loose vegetation was found on the aortic valve that almost occluded the orifice (Figure D). The aortic valve was replaced with a 21-mm mechanical prosthesis (St. Jude Medical, St. Paul, MN, United States). Continued blood loss of more than 200mL/h occurred in the postoperative period. The coagulation profile showed hypocoagulability with fibrinogen of less than 1.5g/L and a platelet count of 20 × 109/L. Hemophagocytic lymphohistiocytosis (HLH) was diagnosed and the patient was started on intravenous methylprednisolone 500mg/d and immunoglobulin 0.5g/kg/d for 3 days and transfusion of packed red blood cells, plasma, platelets, cryoprecipitate, and fibrinogen. The treatment effectively stopped the bleeding. The patient eventually recovered well and was discharged.

HLH is rare and has a mortality of 41%. It is characterized by defective cytotoxic cell control of an initial immune response that progresses to uncontrolled macrophage activity and hypercytokinemia. This activation produces an exaggerated inflammatory response and hypersecretion of cytokines in a so-called cytokine storm.1

According to the HLH-2004 diagnostic guidelines, our case fulfilled 6 of the 8 criteria, namely, fever, splenomegaly, cytopenia, fibrinogen ≤ 1.5g/L, hemophagocytosis in the bone marrow, and ferritin ≥ 500μg/L. After reviewing 2197 adult HLH cases, Ramos-Casals et al.1 determined that viral infection was the most common cause of HLH (34.68%); fungus (1.68%) was a less frequent trigger. K. ohmeri is a rare fungal pathogen in humans. There is no published report of secondary HLH related to K. ohmeri infection and we believe it to be a new trigger of HLH.

K. ohmeri is commonly used in the food industry for its fermentation ability. The first case of human infection was reported in 1998, and the pathogen, isolated from pleural fluid, was considered a contaminant.2K. ohmeri endocarditis has thus far only been reported in 4 patients.3–6 The characteristics of all 5 cases (including the present patient) are described in the Table. The patients were all male with predisposing factors. The mitral valve was the most commonly involved valve. The present patient is the first reported case with aortic valve involvement. Vegetations were larger than 10mm in 4 of the 5 patients. This feature is associated with fungal endocarditis and favors the occurrence of embolic events. A combination of valve replacement and an antifungal drug was used to treat K. ohmeri endocarditis in 4 of the 5 patients. One patient, treated by antifungal therapy alone, died before planned surgery could be performed; consequently, we believe that surgery should be urgently performed to treat K. ohmeri endocarditis. Compared with the previously reported cases, the present patient had a longer duration that induced more severe multiorgan injuries, which may be the potential cause of the associated HLH.

Table.

Summary of the Characteristics of the Patients With K. ohmeri Endocarditis

Age/sex  Predisposing factor(s)  Duration  Involved valves  Vegetation dimension  Embolic event  Organomegaly  Hemocytopenia  Treatment  Result  Reference 
76 y/M  MVR+CABG, pacemaker implantation  1 d  Prosthetic mitral valve  5-cm length  Splenic infarction  No  Thrombocytopenia  MVR, pacemaker removal, AmB lipid complex  Recovered  Reina et al.3 
42 y/M  Heroin addict, hepatitis C, peripheral vasculopathy  2 wk  Mitral valve with rheumatic disease  20mm in largest diameter  Occlusion of the distal left popliteal artery  No  Erythropenia  Embolectomy, MVR, liposomal AmB  Recovered  João et al.4 
43 y/M  Hepatitis B  2 mo  Mitral valve with rheumatic disease  Not described  No  No  Erythropenia  MVR+TVP, itraconazole  Recovered  Yanghua et al.5 
40 d/M  Neonatal seizures, necrotizing enterocolitis  20 d  Tricuspid valve  11.1 × 6.4 mm  No  No  Erythropenia  AmB  Death  Sundaram et al.6 
57 y/M  Multiple trauma, broad-spectrum antibiotic therapy, long-term use of prednisone  3 mo  Aortic valve  30 × 12 mm  Occlusion of the distal right popliteal artery  Splenomegaly  Pancytopenia  AVR, voriconazole  Recovered  Present case 

AmB, amphotericin B; AVR, aortic valve replacement; CABG, coronary artery bypass grafting; M, male; MVR, mitral valve replacement; TVP, tricuspid valve plasty.

In the present case, K. ohmeri emerged as a rare infectious fungus and was accompanied by a life-threatening HLH, which undoubtedly complicated endocarditis diagnosis and treatment. We believe that multidisciplinary collaboration can favor early recognition and diagnosis and will eventually result in a specific therapy.

Acknowledgments

This work was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801].

References
[1]
M. Ramos-Casals, P. Brito-Zerón, A. López-Guillermo, M.A. Khamashta, X. Bosch.
Adult haemophagocytic syndrome.
Lancet., 383 (2014), pp. 1503-1516
[2]
M.M. Bergman, D. Gagnon, G.V. Doern.
Pichia ohmeri fungemia.
Diagn Microbiol Infect Dis., 30 (1998), pp. 229-231
[3]
J.P. Reina, D.H. Larone, J.R. Sabetta, K.K. Krieger, B.J. Hartman.
Pichia ohmeri prosthetic valve endocarditis and review of the literature.
Scand J Infect Dis., 34 (2002), pp. 140-141
[4]
I. João, J. Duarte, C. Cotrim, et al.
Native valve endocarditis due to Pichia ohmeri.
Heart Vessels., 16 (2002), pp. 260-263
[5]
Q. Yanghua, W. Weiwei, L. Yang, X. Jian, S. Qian.
Isolation, identification, and antifungal susceptibility test for Kodamaea ohmeri: a case report on endocarditis.
Journal of Medical Colleges of PLA., 25 (2010), pp. 252-256
[6]
P.S. Sundaram, S. Bijulal, J.A. Tharakan, M. Antony.
Kodamaea ohmeri tricuspid valve endocarditis with right ventricular inflow obstruction in a neonate with structurally normal heart.
Ann Pediatr Cardiol., 4 (2011), pp. 77-80
Copyright © 2016. Sociedad Española de Cardiología
Idiomas
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.